Investment Thesis

and justify an increase in position size.

Competitive Moat

characterized by intangible assets, specifically regulatory approvals and a strong brand reputation cultivated over nearly 130 years. Its extensive network within healthcare providers creates significant switching costs, as institutions tend to rely on established suppliers for critical medical equipment. This advantage is durable over the next 5-10 years; however, the emergence of nimble competitors leveraging innovative technologies, particularly in diagnostics and minimally invasive surgery, poses a threat to BD's market share.

Growth Engine

Future revenue growth for BDX is driven by several factors, including its expansive total addressable market (TAM) in global healthcare, which is projected to grow as population health needs evolve. The company is well-positioned to capitalize on the increasing demand for automated and integrated healthcare solutions, particularly in IV medication management and diagnostic testing. This growth is primarily organic, bolstered by new product introductions and geographic expansion into emerging markets. BDX is gaining market share through strategic investments in R&D, enhancing its product offerings to meet evolving healthcare challenges.